Trends in Legionnaires Disease, : Declining Mortality and New Patterns of Diagnosis
|
|
- Grace Boyd
- 6 years ago
- Views:
Transcription
1 MAJOR ARTICLE Trends in Legionnaires Disease, : Declining Mortality and New Patterns of Diagnosis Andrea L. Benin, a Robert F. Benson, and Richard E. Besser Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia New diagnostic tests and empirical therapy for pneumonia may have important ramifications for the identification, treatment, and control of legionnaires disease (LD). To determine trends in the epidemiology of LD, we analyzed data for from the passive surveillance system of the Centers for Disease Control and Prevention. During this time period, there were 6757 confirmed cases of LD (median annual number, 360 cases/year). Diagnosis by culture and by direct fluorescent antibody and serologic testing decreased significantly; diagnosis by urine antigen testing increased from 0% to 69%. The frequency of isolates other than Legionella pneumophila serogroup 1 (LP1) decreased from 38% to 4% ( P p.003). The case-fatality rate decreased significantly, from 34% to 1% ( P!.001) for all cases, from 46% to 14% ( P!.0001) for nosocomial cases, and from 6% to 10% ( P p.05) for community-acquired cases. LD-related mortality has decreased dramatically. The decrease in culture-based diagnosis limits the recognition of non-lp1 disease and impairs outbreak investigation, because fewer Legionella isolates are provided for further examination. Legionella was first recognized as a pathogen in 1977, when Legionella pneumophila was identified as the agent responsible for an outbreak of severe pneumonia among attendees at the American Legion convention in Philadelphia in 1976 [1]. To understand the risk factors for infection, trends in disease incidence, and opportunities for prevention, the Centers for Disease Control and Prevention (CDC) began conducting passive surveillance for legionellosis in Previous analyses of CDC surveillance data have documented that elderly individuals, smokers, and people with underlying respiratory or immunocompromising Received 8 February 00; revised 4 June 00; electronically published 14 October 00. a Present affiliation: Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, New Haven, Connecticut. Reprints or correspondence: Dr. Richard E. Besser, MSC-3, 1600 Clifton Rd., Atlanta, GA (rbesser@cdc.gov). Clinical Infectious Diseases 00;35: This article is in the public domain, and no copyright is claimed /00/ conditions are at increased risk for legionnaires disease (LD) []. More than one-half of the 146 species of Legionella and 68 distinct serogroups identified have been linked to disease [3 6]. The vast majority of reported cases are caused by L. pneumophila. The last analysis of data from the CDC surveillance system included cases from 1980 to 1989 []. Since then, several important changes in the diagnosis of infections with Legionella and treatment of pneumonia have taken place. These changes have had a direct impact on our ability to identify cases of LD and may have an impact on mortality from LD. A urine antigen test for the diagnosis of LD caused by L. pneumophila serogroup 1 (LP1) was made available in the early 1980s [7 9], and its use has increased considerably in recent years. This test is highly sensitive and specific, and it allows rapid diagnosis of LD. Rapidity of diagnosis is an important advantage of the urine antigen test, because it means that cases can be detected early in the course of infection, when treatment decisions can be affected, unlike diagnosis of LD by other modalities. Disadvantages of the urine antigen Trends in Legionnaires Disease CID 00:35 (1 November) 1039 Downloaded from on 08 April 018
2 test are that non-lp1 strains are not identified and that isolates of Legionella are not obtained, which impairs public health investigations of outbreaks of LD. During the 1990s, macrolide and fluoroquinolone antibiotics were increasingly recommended for empirical treatment of community-acquired pneumonia [10, 11]. Unlike b-lactam agents, these drugs provide good coverage for infections with Legionella. Thus, it is likely that these agents have been used as initial therapy with increasing frequency in treating patients with community-acquired pneumonia resulting from LD. To determine whether use of the urine antigen test has replaced other diagnostic methods and whether this change has led to a shift in reported cases caused by non-lp1 strains, we reviewed surveillance data for In addition, we analyzed trends in the case-fatality rates for LD during this period of changing prescribing patterns, to see whether there has been any change in mortality due to LD. SUBJECTS, MATERIALS, AND METHODS Surveillance for legionellosis. Voluntary passive surveillance for legionellosis has been carried out in the United States since State health departments submit a -page case-report form for each suspected case of LD. No isolates or other specimens are submitted. Although the case-report form has been modified several times, information about patient age, sex, race, travel history, specific laboratory test results for Legionella infection, and the species and serogroup of the infecting pathogen has been consistently collected. Information on outcome and hospital exposure has been collected, although the wording and responses have changed. As of 1999, reporting of LD was mandatory in all states except Oregon and West Virginia [1]. In 00, Oregon also began to require reporting of legionellosis. Definitions. We defined a case patient as a person with pneumonia that was diagnosed by chest radiography and who had at least 1 of the following: isolation of Legionella by culture; detection of Legionella by direct fluorescent antibody (DFA) testing of lung tissue or respiratory secretions; a 4-fold increase, to 1:18, in antibody titer to Legionella in serum between the acute phase and the convalescent phase; and detection of antigen in urine [13]. The currently used definition of nosocomial illness is LD that is confirmed by laboratory testing and occurs in a patient who has been hospitalized continuously for 10 days before the onset of illness [14]. Because of the nature of the questions on the reporting form and changes in the information collected over the surveillance period, we had to use a different definition for nosocomial disease. For this analysis, we defined a case of LD that occurred before 1983 as nosocomial if the affected individual had visited a hospital or been a patient in the hospital during the weeks before the onset of disease; cases that occurred between 1983 and 1987 were considered to be nosocomial if the individual had been a visitor, patient, or employee at a hospital during the weeks before the onset of disease; and cases that occurred between 1987 and 1998 were considered to be nosocomial if the individual had stayed or worked in the hospital as a patient or employee during the weeks before onset, had been hospitalized continuously for 3 days before the onset of infection, or had been discharged from the hospital 10 days before the onset of LD. Because no distinction about the cause of death was made until 1987, we defined case fatality in slightly different ways. From 1980 to 1985, a case was considered fatal if the answer to the question Case fatal? was recorded as yes. After 1987, a case was considered fatal if the more specific question Was death primarily due to LD? was answered yes. In the years between 1985 and 1987, both versions of the data-collection form were in circulation; responses were coded as above, depending on which form was used. We classified cases as outbreak related if it was so indicated on the case-report form. Cases were considered to be part of a nosocomial outbreak if they met the definition for nosocomial infection and if the field for nosocomial outbreak related on the case-report form was checked. Persons whose illness met the definition for nosocomial infection but for whom a non nosocomial outbreak source was listed were not considered to be part of a nosocomial outbreak. Persons who fit the definition for nosocomial infection were excluded from the communityoutbreak category, even if that field was marked on the casereport form. The response rates for the community-outbreak category were too low, however, to permit analysis of that variable. Persons whose reporting forms contained conflicting information about outbreak status were placed into the unknown/missing category. For the purposes of our analysis, persons who reported having traveled during the weeks before the onset of illness were classified as having travel-associated LD. We grouped the months of the year by season: December, January, and February as winter; March, April, and May as spring; June, July, and August as summer; and September, October, and November as fall. Statistical analysis. We compared the race, ethnicity, and sex distribution among persons with LD with that in the general US population, using 1990 census information [15]. We calculated yearly and age-adjusted rates of LD using actual and estimated census population data for Trends in cases per year, deaths per year, case-fatality rates per year, species and serogroup prevalence, and use of diagnostic testing methods were calculated by linear regression, using the PROC REG procedure in SAS version 8 software (SAS Institute) to determine whether the slope of the trend line differed from zero. To determine whether the distribution of 1040 CID 00:35 (1 November) Benin et al. Downloaded from on 08 April 018
3 species and serogroups causing disease had changed over time, we analyzed species and serogroup trends for patients for whom positive culture results had been reported. None of the analyses of case-fatality rates were adjusted for underlying conditions. All reported P values are -tailed. P.05 was considered to be significant. In situations in which patients had data missing for the variable being analyzed, we only included in the calculations those patients for whom data were available. RESULTS From 1980 to 1998, 10,753 case reports were submitted to the CDC; 6757 (63%) of these reports met the case definition for LD. The annual number of cases ranged from 59 in 1986 to 485 in 1988; the median number of cases per year was 360 (figure 1). There was no temporal trend in the number of cases per 100,000 US residents reported per year ( P p.3; R p 0.06). Demographic characteristics. The median age of case patients was 60 years (interquartile range, years). The disease incidence peaked in the year-old age group (figure ). Sixty-five percent of patients were male, compared with 49% of the 1990 US population. Of persons for whom data on race and ethnicity were available, 87% were white/non- Hispanic, 11% were black/non-hispanic, 1.5% were Hispanic, and!1% were American Indian, Native Alaskan, Asian, or Pacific Islander. These proportions are comparable to the racial distribution of the US population in Cases of LD occurred throughout the year, although more were reported during the summer months: 33% of cases occurred in the summer, 6% in the fall, % in the spring, and 19% in the winter. Nosocomial LD. Between 1980 and 1998, 35% of cases (066/5934) met the definition for nosocomial infection. The proportion of cases that were nosocomial varied from a high of 45% in 1986 to a low of 5% in 1997; the proportion decreased over time ( P p.0004; R p 0.5). Of the nosocomial cases for which outbreak information was available, 8% (66/ 951) were associated with an outbreak. Case-fatality rate. Between 1980 and 1998, 0% of case patients (10/610) died. The case-fatality rate decreased dramatically, from a high of 34% in 1985 to 11.5% in 1998 (P!.001; R p 0.6) (figure 3). For nosocomial LD, the overall casefatality rate was 8% (59/1861). This rate also decreased markedly, from a high of 46% in 198 to 14% in 1998 ( P!.0001; R p 0.6). For community-acquired LD, the overall casefatality rate was 14% (496/354); the rate decreased from a high of 6% in 1985 to 10% in 1998 ( P p.05; R p 0.). Use of diagnostic testing. Diagnosis of infection with Legionella was made by urine antigen testing for 16% of patients (1087/6757), by a 4-fold rise in antibody titer for 9% of patients (1979/6757), by DFA testing of respiratory specimens for 31% of patients (083/6757), and by isolation of Legionella species by culture for 45% of patients (3045/6757). For 0% of patients, the diagnosis was made by 11 technique. The proportion of patients who had a positive urine antigen test increased significantly over time ( P!.0001; R p 0.8); the proportion with a 4-fold rise in serological titer decreased stead- Figure 1. Annual no. of cases of legionnaires disease (LD) reported and rate per 100,000 US residents, Trends in Legionnaires Disease CID 00:35 (1 November) 1041 Downloaded from on 08 April 018
4 Figure. No. of cases of legionnaires disease (LD) and rate per 100,000 US residents, by age group, ily over the time period ( P!.0001; R p 0.85). The use of DFA testing or culture to diagnose LD increased from 1980 to 1990 but then decreased after 1990 (DFA, P p.0008 and R p 0.8; culture, P p.0 and R p 0.6) (figure 4). The case-fatality rate over the course of the 19-year study period for persons who had positive results of culture for Legionella but did not have positive results of a urine antigen test reported was 7% (664/458). For persons who did have positive results of a urine antigen test reported but did not have a culture done, it was 10% (70/68). When the analysis was controlled for year of diagnosis, persons who had a culture but no urine antigen testing were significantly more likely to die than Figure 3. Case-fatality rate for community-acquired and nosocomial legionnaires disease in the US population, CID 00:35 (1 November) Benin et al. Downloaded from on 08 April 018
5 Figure 4. Diagnostic testing for Legionella, percentage of all reported cases meeting case definition, by type of test, DFA, direct fluorescent antibody; 4-Fold rise, 4-fold increase in antibody titer. those who had urine antigen testing but no culture or any other diagnostic test (relative risk,.14; 95% CI, 1.6.9; P!.0001). Although mortality decreased over time among persons who had culture and either DFA or serologic testing ( P!.0001; R p 0.78), culture alone ( P!.0001; R p 0.7), or DFA testing alone ( P!.0001; R p 0.75), mortality showed no temporal trend among persons with urine antigen testing alone ( P!.3; R p ) (figure 5). Species and serogroups. Most reported cases of LD were caused by LP1. The next most common isolates were Legionella micdadei, LP6, LP3, and Legionella longbeachae (table 1). When all cases for which serogroup data were available were included in the analysis, the percentage of cases caused by LP1 increased steadily ( P p.01; R p 0.3), especially after 1990 ( P!.0001; R p 0.95). Conversely, the percentage of cases that were not caused by LP1 but for which the serogroup was known decreased, from a high of 8% (60/18) in 1983 to 4% (1/ 33) in 1998 ( P p.001; R p 0.4) (figure 6). Figure 5. Annual mortality rate among US residents with legionnaires disease, by type of diagnostic test, *Denominator is!10 tests per category per year. Trends in Legionnaires Disease CID 00:35 (1 November) 1043 Downloaded from on 08 April 018
6 Table 1. Proportion of legionnaires disease caused by each serogroup and species of Legionella, United States, Species, serogroup All isolates, % (n p 340) Isolates from community-acquired infections, % (n p 159) Isolates from nosocomial infections, % (n p 890) Legionella pneumophila Unknown L. bozemanii L. dumofii L. gormanii L. micdadei L. feeleii L. longbeachae L. jordanis NOTE. Only isolates identified by culture are included. When the analysis was restricted to patients who had positive culture results, LD was caused by LP1 in 51% (118/340); the percentage ranged from 58% (56/97) in 1990 to 91% (98/108) in 1998 and had no temporal trend. An additional 3% (750/ 340) of these patients had LD caused by L. pneumophila with a serogroup that was not specified (table 1). Travel-associated LD. Twenty-one percent (959/4610) of case patients met the definition for travel-associated LD. The percentage of travel-associated disease ranged from 14% in 1983 to 5% in ; there was no temporal trend ( P p.; R p 0.1). DISCUSSION This analysis of surveillance data documents important findings: a dramatic shift in diagnostic testing for LD, from a predominant use of serologic testing to the use of a urine antigen assay, and a 66% decrease in mortality for nosocomial and community-acquired legionellosis combined. The increase in the use of the urine antigen test has had important implications for outbreak control because it effectively allows the identification of outbreaks of LD due to LP1 in hospitals and the community. Recently, urine antigen test results led to the detection and rapid control of an outbreak of LD in an automotive plant that otherwise would have been missed [16]. The introduction of urine antigen testing also has led to the detection of previously unrecognized, ongoing transmission in hospitals. In these hospitals, detection of nosocomial transmission has been followed by corrective action that halted the spread of disease [17]. What are the perils of relying on this test? Although the urine antigen test can be used to effectively diagnose infections with LP1, it is neither licensed nor sensitive for diagnosis of infections caused by other species of Legionella or other L. pneumophila serogroups. Although LP1 is the leading cause of LD in the United States, 10 species of Legionella can cause disease [4]. The use of urine antigen testing has resulted in the preferential diagnosis of LP1 infections. The percentage of non- LP1 cases decreased by 79% between 1983 and The shift in diagnostic testing impairs our ability to detect non-lp1 cases and, as a consequence, our ability to detect and stop outbreaks. After a recent cluster of cases due to L. longbeachae was reported [18], a review of CDC surveillance data for L. longbeachae infections revealed that reports of these infections had decreased during the 1990s as the use of culture for diagnosis of LD had waned (data not shown). Many outbreaks of LD may be unrecognized because of the decrease in the use of culture for diagnosis of pneumonia. The drawbacks to exclusive use of urine antigen testing are not limited to poor detection of LD. Although this test identifies LP1 infections and is more sensitive than culture, public health investigations of outbreaks of LD rely on having both clinical and environmental Legionella isolates. When an outbreak of LD is detected, public health departments conduct both epi CID 00:35 (1 November) Benin et al. Downloaded from on 08 April 018
7 Figure 6. Percentage of legionnaires disease (LD) cases caused by serogroups and species other than Legionella pneumophila serogroup 1 for which the serogroup was known, demiological and environmental investigations to localize the source of transmission. Because attack rates for legionellosis are low and epidemiological studies alone can rarely completely pinpoint the source of transmission, environmental sampling is used to supplement epidemiological associations by providing Legionella isolates that can be compared with clinical isolates by use of molecular subtyping techniques [19]. Without clinical isolates, it is impossible to interpret the findings of environmental investigations, because legionellae are commonly found in the environment; it is not uncommon during outbreak investigations to identify multiple strains of Legionella, including several strains of LP1. What accounts for the documented decrease in mortality among patients with LD? Because the urine antigen test is more sensitive than culture, serologic testing, or DFA testing, it is possible that its use has led to the detection of disease in patients with milder forms of legionellosis, for whom case-fatality rates are lower. Indeed, mortality decreased over time among patients for whom diagnosis was made using culture but not among those for whom diagnosis was made by urine antigen testing; this finding suggests that patients for whom the diagnosis was made by urine antigen testing either were less severely ill or received treatment more quickly. Reporting during the early years of the time period may have been skewed by the application of diagnostic testing to only the sickest patients. Nevertheless, the decrease in mortality persists even when we separate the patients by type of diagnostic test. Another reason for the decrease in mortality may be the changes in empirical antibiotic treatment of patients hospitalized with pneumonia. The American Thoracic Society, in 1993 [11], and the Infectious Diseases Society of America, in 1998 [10], published recommendations for empirical therapy for pneumonia. These guidelines included the use of fluoroquinolones and macrolides, antimicrobial agents that are effective for the treatment of LD. Correspondingly, the use of these agents has steadily increased in the United States. Data from 3 recent, large outbreaks of LD from The Netherlands, Spain, and Australia suggest that countries using these agents as empirical therapy for patients hospitalized for community-acquired pneumonia have lower mortality rates during outbreaks of LD than do countries using b-lactam antibiotics as first-line agents [0]. These data must be interpreted with caution, because surveillance techniques for LD in the United States are insensitive. One population-based study in Ohio estimated the national incidence of LD to be ,500 cases/year [1]. This would mean that only.5% 4.5% of cases are reported to the CDC. Reasons for underreporting could include poor recognition by clinicians of LD as a cause of pneumonia, a lack of routine diagnostic testing, a lack of reporting to health departments, and limited reporting by health departments to the CDC. However, despite underreporting, surveillance data can reveal trends that have important public health implications. What diagnostic tests should be used for suspected cases of LD? Several groups have issued recommendations for the diagnosis of community-acquired and nosocomial pneumonia [14, 4]. These recommendations suggest that, for patients for whom LD is a possible diagnosis and for all patients with Trends in Legionnaires Disease CID 00:35 (1 November) 1045 Downloaded from on 08 April 018
8 nosocomial pneumonia, urine antigen testing and culture of appropriate respiratory secretions be performed. Performing both tests allows rapid diagnosis of LP1 infections, later diagnosis of infection with other legionellae, and availability of isolates. Given that empirical use of fluoroquinolones and extendedspectrum macrolides is successful in treating patients with undiagnosed LD, cost considerations may limit the use of tests to diagnose LD. Formal cost studies are needed to assess the implications of various approaches to the diagnosis of pneumonia. Cost equations must include the important public health implications of not diagnosing LD, including the continued presence of a disease-transmission source in the hospital or community. There has been a remarkable reduction in LD mortality since To continue to reduce mortality, our efforts must be directed at disease prevention. Prevention relies on the identification of sources of transmission and thus requires a diagnostic approach to pneumonia that includes both urine antigen testing and culture for legionellae. References 1. Fraser DW, Tsai TR, Orenstein W, et al. Legionnaires disease: description of an epidemic of pneumonia. N Engl J Med 1977; 97: Marston BJ, Lipman HB, Breiman RF. Surveillance for legionnaires disease: risk factors for morbidity and mortality. Arch Intern Med 1994; 154: Lo Presti F, Riffard S, Meugnier H, et al. Legionella taurinensis sp nov, a new species antigenically similar to Legionella spiritensis. Int J Syst Bacteriol 1999; 49: Benson RF, Fields BS. Classification of the genus Legionella. Semin Respir Infect 1998; 13: Fields BS, Benson RF, Besser RE. Legionella and legionnaires disease: 5 years of investigation. Clin Microbiol Rev 00; 15: Adeleke AA, Fields BS, Benson RF, et al. Legionella drozanskii sp nov, Legionella rowbothamii sp nov and Legionella fallonii sp nov: three unusual new Legionella species. Int J Syst Evol Microbiol 001; 51: Kohler RB, Zimmerman SE, Wilson E, et al. Rapid radioimmunoassay diagnosis of legionnaires disease: detection and partial characterization of urinary antigen. Ann Intern Med 1981; 94: Berdal BP, Farshy CE, Feeley JC. Detection of Legionella pneumophila antigen in urine by enzyme-linked immunospecific assay. J Clin Microbiol 1979; 9: Tilton RC. Legionnaires disease antigen detected by enzyme-linked immunosorbent assay. Ann Intern Med 1979; 90: Bartlett JG, Breiman RF, Mandell LA, File TM Jr. Community-acquired pneumonia in adults: guidelines for management. Infectious Diseases Society of America. Clin Infect Dis 1998; 6: Niederman MS, Bass JB, Campbell GD, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis 1993; 148: Roush S, Birkhead G, Koo D, Cobb A, Fleming D. Mandatory reporting of diseases and conditions by health care professionals and laboratories. JAMA 1999; 8: Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Morb Mortal Wkly Rep 1997; 46: Centers for Disease Control and Prevention. Guidelines for prevention of nosocomial pneumonia. MMWR Morb Mortal Wkly Rep 1997; 46: United States Department of Commerce Census of population United States. Washington, DC: US Government Printing Office, Centers for Disease Control and Prevention. Outbreak of legionnaires disease among automotive plant workers Ohio, 001. MMWR Morb Mortal Wkly Rep 001; 50: Lepine LA, Jernigan DB, Butler JC, et al. A recurrent outbreak of nosocomial legionnaires disease detected by urinary antigen testing: evidence for long-term colonization of a hospital plumbing system. Infect Control Hosp Epidemiol 1998; 19: Centers for Disease Control and Prevention. Legionnaires disease associated with potting soil California, Oregon, and Washington, May June 000. MMWR Morb Mortal Wkly Rep 000; 49: Whitney CG, Hofmann J, Pruckler JM, et al. The role of arbitrarily primed PCR in identifying the source of an outbreak of legionnaires disease. J Clin Microbiol 1997; 35: Navarro C, Garcia-Fulgueiras A, Kool J, et al. Update on the outbreak of legionnaires disease in Murcia, Spain. Eurosurveillance Wkly 001; 9: Available at: Accessed 30 September Marston BJ, Plouffe JF, File TM, et al. Incidence of communityacquired pneumonia requiring hospitalization results of a population-based active surveillance study in Ohio. Arch Intern Med 1997; 157: Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 001; 163: Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 000; 31: Heffelfinger J, Dowell S, Jorgensen J, et al. Management of communityacquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med 000; 160: CID 00:35 (1 November) Benin et al. Downloaded from on 08 April 018
Increasing Incidence of Legionellosis in the United States, : Changing Epidemiologic Trends
MAJOR ARTICLE Increasing Incidence of Legionellosis in the United States, 1990 2005: Changing Epidemiologic Trends Karen Neil and Ruth Berkelman Department of Epidemiology, Emory University, Atlanta, Georgia
More informationNE Regional AIHA Conference Legionella Analytical Developments. Dec 5, 2014
NE Regional AIHA Conference Legionella Analytical Developments Dec 5, 2014 Diane Miskowski EMSL Analytical Inc. Cinnaminson, NJ 856-303-2528 dmiskowski@emsl.com EMSL Analytical, Inc.-Copyright 2011 1 Legionella
More informationEvaluation of the Oxoid Xpect Legionella test kit for Detection of Legionella
JCM Accepts, published online ahead of print on 6 May 2009 J. Clin. Microbiol. doi:10.1128/jcm.00397-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationReceived 3 August 2005/Returned for modification 13 September 2005/Accepted 13 January 2006
CLINICAL AND VACCINE IMMUNOLOGY, Mar. 2006, p. 361 364 Vol. 13, No. 3 1556-6811/06/$08.00 0 doi:10.1128/cvi.13.3.361 364.2006 Copyright 2006, American Society for Microbiology. All Rights Reserved. Evaluation
More informationCommunity-Acquired Pneumonia OBSOLETE 2
Community-Acquired Pneumonia OBSOLETE 2 Clinical practice guidelines serve as an educational reference, and do not supersede the clinical judgment of the treating physician with respect to appropriate
More informationClinical Outcomes for Hospitalized Patients with Legionella Pneumonia in the Antigenuria Era: The Influence of Levofloxacin Therapy
MAJOR ARTICLE Clinical Outcomes for Hospitalized Patients with Legionella Pneumonia in the Antigenuria Era: The Influence of Levofloxacin Therapy Analía Mykietiuk, 1 Jordi Carratalà, 1 Núria Fernández-Sabé,
More informationCurrent and Emerging Legionella Diagnostics
Current and Emerging Legionella Diagnostics Nicole Wolter Centre for Respiratory Diseases and Meningitis (CRDM) National Institute for Communicable Diseases nicolew@nicd.ac.za 7 th FIDSSA Conference, Cape
More informationAnnual Epidemiological Report
July 2018 Annual Epidemiological Report 1 Legionellosis in Ireland, 2017 Key Facts There were 25 cases of Legionnaires disease notified in Ireland in 2017 The rate per million population increased from
More informationMAJOR ARTICLE. Atypical Pneumonia in Thailand CID 2007:45 (15 December) e147
MAJOR ARTICLE Epidemiology of Severe Pneumonia Caused by Legionella longbeachae, Mycoplasma pneumoniae, and Chlamydia pneumoniae: 1-Year, Population- Based Surveillance for Severe Pneumonia in Thailand
More informationA community outbreak of Legionnaires disease linked to hospital cooling towers: an epidemiological method to calculate dose of exposure
International Epidemiological Association 1999 Printed in Great Britain International Journal of Epidemiology 1999;28:353 359 A community outbreak of Legionnaires disease linked to hospital cooling towers:
More informationIncidence per 100,000
Streptococcus pneumoniae Surveillance Report 2005 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Department of Human Services Updated: March 2007 Background
More informationPertussis. West Virginia Electronic Disease Surveillance System
Pertussis Electronic Disease Surveillance System Division of Surveillance and Disease Control Infectious Disease Epidemiology Program : 304-558-5358 or 800-423-1271 in Fax: 304-558-8736 Investigation Information
More informationThe authors assessed drug susceptibility patterns
Drug Resistance Among Tuberculosis Patients, 1991 and 1992 New York City, CYNTHIA R. DRIVER, RN, MPH THOMAS R. FRIEDEN, MD, MPH ALAN B. BLOCH, MD, MPH IDA M. ONORATO, MD All the authors are with the Division
More informationLegionella Resources on the World Wide Web
INVITED ARTICLE SURFING THE WEB Victor L. Yu, Section Editor Legionella Resources on the World Wide Web Stefano Bassetti 1 and Andreas F. Widmer 2 Divisions of 1 Infectious Diseases and 2 Hospital Epidemiology,
More informationA proactive approach to prevention of health care acquired Legionnaires disease: The Allegheny County (Pittsburgh) experience
A proactive approach to prevention of health care acquired Legionnaires disease: The Allegheny County (Pittsburgh) experience Cheryl L. Squier, RN, CIC, b,c JanetE.Stout,PhD, c,d Sharon Krsytofiak, MS,
More informationHAEMOPHILUS INFLUENZAE INVASIVE DISEASE
23 Annual Morbidity Report HAEMOPHILUS INFLUENZAE INVASIVE DISEASE CRUDE DATA 35 Annual Incidence a LA County.37 California b. United States c.2 Age at Diagnosis Mean 4. years Median 36. years Range Birth
More informationAntimicrobial Stewardship in Community Acquired Pneumonia
Antimicrobial Stewardship in Community Acquired Pneumonia Medicine Review Course 2018 Dr Lee Tau Hong Consultant Department of Infectious Diseases National Centre for Infectious Diseases Scope 1. Diagnosis
More informationTexas Influenza Summary Report, Season (September 28, 2008 April 11, 2009)
Texas Influenza Summary Report, 2008 2009 Season (September 28, 2008 April 11, 2009) Background Influenza and influenza-like illnesses (ILI) were last reportable by law in any county in Texas in 1993 (1).
More information3. Rapidly recognize influenza seasons in which the impact of influenza appears to be unusually severe among children.
07-ID-14 Committee: Title: Infectious Disease Influenza-Associated Pediatric Mortality Statement of the Problem: In 2004, CSTE adopted influenza-associated pediatric mortality reporting with a provision
More informationOutbreak of travel-associated Legionnaires' disease Palmanova, Mallorca (Spain), September October Main conclusions and options for response
RAPID RISK ASSESSMENT Outbreak of travel-associated Legionnaires' disease Palmanova, Mallorca (Spain), September October 2017 23 October 2017 Main conclusions and options for response An increase in Legionnaires
More informationSurveillance, Reporting and Control of Influenza and Pertussis. Steve Fleming, EdM Hillary Johnson, MHS Epidemiologists Immunization Program, MDPH
Surveillance, Reporting and Control of Influenza and Pertussis Steve Fleming, EdM Hillary Johnson, MHS Epidemiologists Immunization Program, MDPH Disclosures The speaker has no financial interest or conflict
More informationTHIS IS AN OFFICIAL NH DHHS HEALTH ALERT
THIS IS AN OFFICIAL NH DHHS HEALTH ALERT Distributed by the NH Health Alert Network Health.Alert@nh.gov August 25, 2018 0800 EDT NH-HAN 20180825 Cluster of Legionella pneumophila Pneumonia (Legionnaire
More informationLegionnella. You can t t see it but you can catch it. Dr Charmaine Gauci MD, MSc, PhD Head of Disease Surveillance Unit
Legionnella You can t t see it but you can catch it Dr Charmaine Gauci MD, MSc, PhD Head of Disease Surveillance Unit Legionella infections First documented outbreak name from 221 cases of pneumonia occurred
More informationPlease evaluate this material by clicking here:
EPI Case Study 3: Cross-Sectional, Case-Control, and Cohort Studies Identification of TB Risk Time to Complete Exercise: 60 minutes LEARNING OBJECTIVES At the completion of this module, participants should
More informationImportance of Atypical Pathogens of Community-Acquired Pneumonia
S35 Importance of Atypical Pathogens of Community-Acquired Pneumonia Joseph F. Plouffe Departments of Internal Medicine and Medical Microbiology and Immunology, Ohio State University College of Medicine,
More informationFact Sheet: Legionellosis March 2017
Fact Sheet Fact Sheet: Legionellosis March 2017 Brought to you by the APSP Recreational Water Quality Committee (RWQC) I. INTRODUCTION Legionellosis is an infection caused by the bacterium Legionella.
More informationDecline in Mortality Due to Varicella after Implementation of Varicella Vaccination in the United States
The new england journal of medicine original article Decline in Mortality Due to Varicella after Implementation of Varicella Vaccination in the United States Huong Q. Nguyen, M.P.H., Aisha O. Jumaan, Ph.D.,
More informationSalt Lake County Annual Influenza Report Season Bureau of Epidemiology
Number of Cases Salt Lake County Annual Influenza Report 6-7 Season Bureau of Epidemiology Introduction Table of Contents Introduction The 6-7 influenza season saw 6 confirmed influenza-associated hospitalizations
More informationLegionnaire s disease is a febrile illness with pneumonia. The Radiologic Manifestations of Legionnaire s Disease*
The Radiologic Manifestations of Legionnaire s Disease* Michael J. Tan, MD; James S. Tan, MD, FCCP; Robert H. Hamor, MD; Thomas M. File, Jr., MD, FCCP; Robert F. Breiman, MD; and the Ohio Community-Based
More informationMinnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending February
More informationLegionnaires Disease: Epidemiology and Outbreak Investigation
Legionnaires Disease: Epidemiology and Outbreak Investigation Ellen Laine, JD, MPH Emerging Infections Unit Infectious Disease Epidemiology, Prevention and Control Division History of Legionnaires Disease
More informationMinnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending March
More informationGroup B Streptococcus
Group B Streptococcus (Invasive Disease) Infants Younger than 90 Days Old DISEASE REPORTABLE WITHIN 24 HOURS OF DIAGNOSIS Per N.J.A.C. 8:57, healthcare providers and administrators shall report by mail
More informationStreptococcus Pneumoniae
Streptococcus Pneumoniae (Invasive Pneumococcal Disease) DISEASE REPORTABLE WITHIN 24 HOURS OF DIAGNOSIS Per N.J.A.C. 8:57, healthcare providers and administrators shall report by mail or by electronic
More informationPertussis: An Emerging Infection. Holly K. Ehrke. Ferris State University
Running head: PERTUSSIS AN EMERGING INFECTION 1 Pertussis: An Emerging Infection Holly K. Ehrke Ferris State University PERTUSSIS AN EMERGING INFECTION 2 Abstract Pertussis is a highly contagious disease
More informationHuman Infection with Novel Influenza A Virus Case Report Form
Human Infection with Novel Influenza A Virus Case Report Form Form Approved OMB No. 0920-0004 Exp. Date 6/30/2013 Reporter Information State: Date reported to state/local health department: / / (MM/DD/YYYY)
More informationMinnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending February
More informationPertussis Epidemiology and Vaccine Impact in the United States
Pertussis Epidemiology and Vaccine Impact in the United States Stacey Martin, MSc Epidemiology Team Lead Meningitis and Vaccine Preventable Diseases Branch Centers for Disease Control and Prevention Presented
More informationWeekly Influenza & Respiratory Illness Activity Report
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending February
More informationUtah Influenza Report This report contains data through the week ending 12/15/2012 (MMWR week 50).
This report contains data through the week ending 12/15/212 (MMWR week 5). Overview of Influenza Surveillance: Surveillance for the 212 213 influenza season officially began on September 3, 212. The Utah
More informationRunning head: INFLUENZA VIRUS SEASON PREPAREDNESS AND RESPONSE 1
Running head: INFLUENZA VIRUS SEASON PREPAREDNESS AND RESPONSE 1 Electron micrograph of H1N1 Virus (CDC, 2009) Influenza Virus Season Preparedness and Response Patricia Bolivar Walden University Epidemiology
More informationMinnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending April
More informationInfluenza Season and EV-D68 Update. Johnathan Ledbetter, MPH
2014-2015 Influenza Season and EV-D68 Update Johnathan Ledbetter, MPH 2014-2015 Influenza Season Influenza Reporting Individual cases are not reportable in the state of Texas Situations where influenza
More informationLegionnaires disease in Europe: all quiet on the eastern front?
EDITORIAL LEGIONNAIRES DISEASE IN EUROPE Legionnaires disease in Europe: all quiet on the eastern front? Julien Beauté, Emmanuel Robesyn and Birgitta de Jong, on behalf of the European Legionnaires Disease
More informationEDUCATIONAL COMMENTARY PERTUSSIS
EDUCATIONAL COMMENTARY PERTUSSIS Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click on Earn CE Credits
More informationMISMS: International influenza research activities at the Fogarty International Center, NIH
MISMS: International influenza research activities at the Fogarty International Center, NIH Stacey Knobler and Gerardo Chowell For the Multinational Influenza Seasonal Mortality Study Group (MISMS) Division
More informationEpidemiology and Etiology of Community-Acquired Pneumonia 761 Lionel A. Mandell
LOWER RESPIRATORY TRACT INFECTIONS Preface Thomas M. File, Jr xiii Community-Acquired Pneumonia: Pathophysiology and Host Factors with Focus on Possible New Approaches to Management of Lower Respiratory
More informationTitle: Public Health Reporting and National Notification for Shigellosis
11-ID-19 Committee: Infectious Title: Public Health Reporting and National Notification for Shigellosis I. Statement of the Problem Currently, case confirmation for Shigellosis is dependent on isolation
More informationPCR Is Not Always the Answer
PCR Is Not Always the Answer Nicholas M. Moore, PhD(c), MS, MLS(ASCP) CM Assistant Director, Division of Clinical Microbiology Assistant Professor Rush University Medical Center Disclosures Contracted
More informationAdult Immunizations & the Workplace
Adult Immunizations & the Workplace Samuel B. Graitcer, MD Office of Associate Director for Adult Immunizations Immunization Services Division National Center for Immunization & Respiratory Diseases Immunization
More informationMeasles Surveillance in the United States: An Overview
SUPPLEMENT ARTICLE Measles Surveillance in the United States: An Overview Dalya Güriş, Rafael Harpaz, Susan B. Redd, Natalie J. Smith, a and Mark J. Papania National Immunization Program, Centers for Disease
More informationMinnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending March
More informationSource: Portland State University Population Research Center (
Neisseria meningitidis Surveillance Report 2009 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Health Authority Updated: June 2011 Background The Active
More informationInfluence of Social Media on an Acute Respiratory Outbreak at a High Profile Party Venue Los Angeles, February 2011
Influence of Social Media on an Acute Respiratory Outbreak at a High Profile Party Venue Los Angeles, February 2011 Dawn Terashita, MD, MPH Acute Communicable Disease Control Los Angeles County Department
More informationMinnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending January
More informationMinnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending October
More informationVACCINE-PREVENTABLE DISEASES (VPDS): CURRENT TRENDS
VACCINE-PREVENTABLE DISEASES (VPDS): CURRENT TRENDS Adult Immunization Conference April 10, 2018 Steve Fleming, EdM stephen.fleming@state.ma.us Presenter Disclosure Information I, Steve Fleming, have been
More informationCommunity Acquired Pneumonia. Background & Rationale to North American Guidelines. Lionel Mandell MD FRCPC Brussels Belgium
Community Acquired Pneumonia Background & Rationale to North American Guidelines Lionel Mandell MD FRCPC Brussels Belgium Consider Impact of the disease Issues to reflect upon Impact of the Disease 3-4
More informationControl of Canine Influenza in Dogs Questions, Answers, and Interim Guidelines October 17, 2005
Control of Canine Influenza in Dogs Questions, Answers, and Interim Guidelines October 17, 2005 The following document has been developed via consultation among the American Veterinary Medical Association,
More informationPatterns of adolescent smoking initiation rates by ethnicity and sex
ii Tobacco Control Policies Project, UCSD School of Medicine, San Diego, California, USA C Anderson D M Burns Correspondence to: Dr DM Burns, Tobacco Control Policies Project, UCSD School of Medicine,
More informationNQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form
Last Updated: Version 3.2 NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Set: Pneumonia (PN) Set Measure ID #: Measure Information Form Performance Measure Name: Pneumococcal Vaccination
More informationMinnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending December
More informationCalifornia Influenza Surveillance Project California Department of Public Health. Influenza Update
California Influenza Surveillance Project California Department of Public Health 2008-2009 Influenza Update Influenza Surveillance for August 6 August 12, 2009 As the current H1N1 pandemic unfolds, CDPH
More informationNational Legionnaires Disease Surveillance, Outbreak Detection, and Response
National Center for Immunization & Respiratory Diseases National Legionnaires Disease Surveillance, Outbreak Detection, and Response Ally Binder, MS Surveillance Epidemiologist Respiratory Diseases Branch
More informationShow me the evidence! Water can cause infection and illness if hospital water systems are not properly engineered and managed 6/29/2017
Key Takeaways can May 5, 2017 HEALTHCARE PLUMBING SYSTEMS: PUBLIC HEALTH RISKS ASSOCIATED WITH LEGIONNAIRES DISEASE AND OTHER HEALTHCARE-ASSOCIATED INFECTIONS JOHN HANLIN AND IAN EISNER NALCO WATER A DIVISION
More informationMaking the Right Call With. Pneumonia. Community-acquired pneumonia (CAP) is a. Community-Acquired. What exactly is CAP?
Making the Right Call With Community-Acquired Pneumonia In this article: By Thomas J. Marrie, MD The case of Allyson Allyson, 32, presented to the emergency department with a 48-hour history of anorexia,
More informationImpact of Recurrent Epidemics of Hepatitis A Virus Infection on Population Immunity Levels: Bristol Bay, Alaska
1081 Impact of Recurrent Epidemics of Hepatitis A Virus Infection on Population Immunity Levels: Bristol Bay, Alaska Dolly Peach, 1,a Brian J. McMahon, 1,2 Lisa Bulkow, 1 Elizabeth Funk, 3 Rafael Harpaz,
More informationInfluenza-Associated Pediatric Mortality Case Report Form Form Approved OMB No
Influenza-Associated Pediatric Mortality Case Report Form Form Approved OMB No. 0920-0004 STATE USE ONLY DO NOT SEND INFORMATION IN THIS SECTION TO CDC Last Name: First Name: County: Address: City: State,
More informationInfection control in aged care facilities 3 rd February 2019
Infection control in aged care facilities 3 rd February 2019 A/Prof. Paul Griffin FRACP, FRCPA, FACTM, AFACHSM, FIML, MBBS, BSc(Hons) Infectious Diseases Physician and Clinical Microbiologist Director
More informationInfluenza-Associated Pediatric Deaths Case Report Form
STATE USE ONLY DO NOT SEND INFORMATION IN THIS SECTION TO CDC Form approved OMB No. 0920-0007 Last Name: First Name: County: Address: City: State, Zip: Patient Demographics 1. State: 2. County: 3. State
More informationEPIDEMIOLOGY SURVEILLANCE REPORT Northeast Region. Namitha Reddy Regional Coordinator North/Central West Region
EPIDEMIOLOGY SURVEILLANCE REPORT Northeast Region Namitha Reddy Regional Coordinator North/Central West Region 1 This report is for use by Public Health Officials only and not for public distribution.
More informationLegionellosis Outbreak-Genesee County, June, 2014 March, Summary Analysis
Legionellosis Outbreak-Genesee County, June, 2014 March, 2015 Summary Analysis Michigan Department of Health and Human Services Genesee County Health Department (This report was edited on January 15, 2016
More information2009 (Pandemic) H1N1 Influenza Virus
2009 (Pandemic) H1N1 Influenza Virus September 15, 2009 Olympia, Washington Anthony A Marfin Washington State Department of Health Goals Understand current situation & pattern of transmission of 2009 H1N1
More informationPrevalence of Autism Spectrum Disorders --- Autism and Developmental Disabilities Monitoring Network, United States, 2006
Surveillance Summaries December 18, 2009 / 58(SS10);1-20 Prevalence of Autism Spectrum Disorders --- Autism and Developmental Disabilities Monitoring Network, United States, 2006 Autism and Developmental
More informationINFLUENZA (Outbreaks; hospitalized or fatal pediatric cases)
INFLUENZA (Outbreaks; hospitalized or fatal pediatric cases) 1. Agent: Influenza viruses A, B, and C. Only influenza A and B are of public health concern since they are responsible for epidemics. 2. Identification:
More informationCenters for Disease Control and Prevention U.S. INFLUENZA SEASON SUMMARY*
1 of 6 11/8/2012 1:35 PM Centers for Disease Control and Prevention 2004-05 U.S. INFLUENZA SEASON SUMMARY* NOTE: This document is provided for historical purposes only and may not reflect the most accurate
More informationChickenpox Death. West Virginia Electronic Disease Surveillance System
Chickenpox Death Electronic Disease Surveillance System Division of Surveillance and Disease Control Infectious Disease Epidemiology Program Phone: 304-558-5358 or 800-423-1271 in Fax: 304-558-8736 Investigation
More informationInfluenza A(H1N1)2009 pandemic Chronology of the events in Belgium
Arch Public Health 2010, 68, 48-52 Influenza A(H1N1)2009 pandemic Chronology of the events in Belgium by Litzroth A 1, Gutiérrez I 1,2, Hammadi S 1 Keywords Belgium, chronology, epidemiology, influenza
More informationWeekly Influenza & Respiratory Illness Activity Report
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending March
More informationEpidemiology Update Hepatitis A
December 2011 Epidemiology Update Hepatitis A Hepatitis A Key Points Between 2000 and 2010, 209 cases of hepatitis A were reported in Hennepin County residents. This represents 30% of the cases reported
More informationChapter 1 Overview of Tuberculosis Epidemiology in the United States
Chapter 1 Overview of Tuberculosis Epidemiology in the United States Table of Contents Chapter Objectives.... 1 Progress Toward TB Elimination in the United States... 3 TB Disease Trends in the United
More informationInfluenza Season, Boston
2016-2017 Influenza Season, Boston Infectious Disease Bureau Boston Public Health Commission Boston Public Health Commission Influenza Surveillance: Boston, 2016-2017 Influenza cases diagnosed in Boston
More informationpoint-of-care test (POCT) Definition: an analytical or diagnostic test undertaken in a setting distinct from a normal hospital or non-hospital
point-of-care test (POCT) Definition: an analytical or diagnostic test undertaken in a setting distinct from a normal hospital or non-hospital laboratory performed by a health care professional or non-medical
More informationAustin Public Health Epidemiology and Disease Surveillance Unit. Travis County Influenza Surveillance
Travis County Influenza Surveillance Summary Season 2016-2017 (Data through the week ending March 18, 2017). Travis County influenza and influenza-like illness (ILI) activity: Since March 18 th, influenza
More informationCases in employees. Cases. Day of onset (July)
Cases in employees 70 60 50 Cases 40 30 20 10 0 0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 Day of onset (July) 70 60 50 40 Cases 30 Cases in employees and visitors Employees Visitors 20 10 0 0 2 4 6 8
More informationPERTUSSIS The Unpredictable Burden of Disease. Lawrence D. Frenkel, MD, FAAP AAP/Novartis Grand Rounds Webinar February 7, 2013
PERTUSSIS The Unpredictable Burden of Disease Lawrence D. Frenkel, MD, FAAP AAP/Novartis Grand Rounds Webinar February 7, 2013 Pertussis Agent Bordetella pertussis Nonmotile, fastidious, gram-negative,
More informationLEARNING FROM OUTBREAKS: SARS
LEARNING FROM OUTBREAKS: SARS IFIC - APECIH 2017 KATHRYN N. SUH, MD, FRCPC 29 SEPTEMBER 2017 www.ottawahospital.on.ca Affiliated with Affilié à SEVERE ACUTE RESPIRATORY SYNDROME (SARS) Nov 2002 southern
More informationLegionellosis Water Management and Investigation Case Study
Legionellosis Water Management and Investigation Case Study Michigan Department of Health and Human Services Bryce Spiker, MPH Legionellosis Epidemiologist Mike Wesenberg Environmental Health Specialist
More informationILI Syndromic Surveillance
ILI Syndromic Surveillance Race/ethnicity of adult respondents with influenza-like illness (ILI) in the U.S., Behavioral Risk Factor Surveillance System (BRFSS), Sept 1- Sep 30, 2009 Race/ethnicity I
More informationCitation for published version (APA): IJzerman, E. P. F. (2009). Progress in diagnostics and prevention of Legionnaires' disease [S.n.
University of Groningen Progress in diagnostics and prevention of Legionnaires' disease IJzerman, Eddy Peter Frans IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if
More informationBC MHOs, PHNLs, ICPs, ERDOCs, IDSPEC, MEDMICRO, AMBULANCE, BCCDC Internal Groups, National Surveillance Network Partners
To: Subject: Purpose: Action required: Recommendations: BC MHOs, PHNLs, ICPs, ERDOCs, IDSPEC, MEDMICRO, AMBULANCE, BCCDC Internal Groups, National Surveillance Network Partners November 1, 2013 Emerging
More informationSporadic and epidemic community legionellosis: two faces of the same illness
Eur Respir J 2007; 29: 138 142 DOI: 10.1183/09031936.00077206 CopyrightßERS Journals Ltd 2007 Sporadic and epidemic community legionellosis: two faces of the same illness N. Sopena*, L. Force #, M.L. Pedro-Botet*,
More informationTo develop guidelines for the use of appropriate antibiotics for adult patients with CAP and guidance on IV to PO conversion.
Page 1 of 5 TITLE: COMMUNITY-ACQUIRED PNEUMONIA (CAP) EMPIRIC MANAGEMENT OF ADULT PATIENTS AND IV TO PO CONVERSION GUIDELINES: These guidelines serve to aid clinicians in the diagnostic work-up, assessment
More informationTrends in Pneumonia and Influenza Morbidity and Mortality
Trends in Pneumonia and Influenza Morbidity and Mortality American Lung Association Epidemiology and Statistics Unit Research and Health Education Division November 2015 Page intentionally left blank Introduction
More informationMONTHLY NOTIFIABLE DISEASE SURVEILLANCE REPORT
ISSN 2324-254X May 2016 MONTHLY NOTIFIABLE DISEASE SURVEILLANCE REPORT Data contained within this monthly report is based on information recorded on EpiSurv by Public Health Service (PHS) staff as at 20
More informationOpen Access RESEARCH ARTICLE. Research article. BioMed Central
RESEARCH ARTICLE Open Access Research article Clinical features and predictors of mortality in admitted patients with community- and hospital-acquired legionellosis: A Danish historical cohort study Sanne
More informationSensitivity of three serum antibody tests in a large outbreak of Legionnaires disease in the Netherlands
Journal of Medical Microbiology (2006), 55, 561 566 DOI 10.1099/jmm.0.46369-0 Sensitivity of three serum antibody tests in a large outbreak of Legionnaires disease in the Netherlands Ed P. F. Yzerman,
More informationStep 1: Learning Objectives
SARS Outbreak Study 2 This week in Epiville, you will continue with the remaining steps of the outbreak investigation and begin to learn how to frame a hypothesis, design a study, and draw conclusions
More information